Home » World Health Organization (WHO) » Page 16

World Health Organization (WHO)

Agenda Item 6b: Changes in the scope of control

Documents: E/CN.7/2016/9 and E/CN.7/2016/CRP.2 Chair: Philippines informed the secretariat that it does not oppose the scheduling of any of the proposed substances. Commission will examine recommendations on the seven substances in accordance with the provisions of the 1971 convention, and should decide what action, if any, it wishes to take. Before moving on to a vote …

Read more

Agenda Item 6: Implementation of the international drug control treaties

a) Challenges and future work of the Commission on Narcotic Drugs and the World Health Organization in the review of substances for possible scheduling recommendations WHO: Who is responsible for evaluating substances and whether they should be scheduled. They also decided which convention they are scheduled. Evidence is essential to our role. The adverse affects of the …

Read more

Side event – The public health elements of drug policy

Side event organised by the World Health Organization. Marie-Paule Kieny, director of health systems and innovation – In January this year, the issue of a public health approach to drug problem was on the agenda of the WHO Executive Board for the first time since 1990. The report that followed emphasised the need for a five-pronged approach: prevention of drug …

Read more